80 FR 15610 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention

Federal Register Volume 80, Issue 56 (March 24, 2015)

Page Range		15610-15610
FR Document		2015-06653

Federal Register, Volume 80 Issue 56 (Tuesday, March 24, 2015)

[Federal Register Volume 80, Number 56 (Tuesday, March 24, 2015)]
[Notices]
[Page 15610]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-06653]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panel (SEP): Initial Review

    In accordance with Section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces a meeting for the initial review of 
applications in response to Funding Opportunity Announcements (FOA) 
GH11-002, Conducting Public Health Research in Thailand by the Ministry 
of Public Health (MOPH); FOA GH12-004M, Conducting Public Health 
Research in South Africa by the National Health Laboratory Service 
(NHLS); FOA GH12-005, Conducting Public Health Research in China; and 
FOA GH14-002, Addressing Emerging Infectious Diseases in Bangladesh.
    Time and Date: 8:30 a.m.-1:00 p.m., EST, April 15, 2015 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance with 
provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., 
and the Determination of the Director, Management Analysis and Services 
Office, CDC, pursuant to Public Law 92-463.
    Matters for Discussion: The meeting will include the initial 
review, discussion, and evaluation of applications received in response 
to FOA GH11-002, Conducting Public Health Research in Thailand by the 
Ministry of Public Health (MOPH); FOA GH12-004, Conducting Public 
Health Research in South Africa by the National Health Laboratory 
Service (NHLS); FOA GH12-005, Conducting Public Health Research in 
China; and FOA GH14-002, Addressing Emerging Infectious Diseases in 
Bangladesh.
    Contact Person for More Information: Hylan Shoob, Scientific Review 
Officer, Center for Global Health (CGH) Science Office, CGH, CDC, 1600 
Clifton Road NE., Mailstop D-69, Atlanta, Georgia 30033, Telephone: 
(404) 639-4796.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. 2015-06653 Filed 3-23-15; 8:45 am]
BILLING CODE 4163-18-P

15610 Federal Register / Vol. 80, No. 56 / Tuesday, March 24, 2015 / Notices

DEPARTMENT OF HEALTH AND DEPARTMENT OF HEALTH AND Prevention and the Agency for Toxic
HUMAN SERVICES HUMAN SERVICES Substances and Disease Registry.

Centers for Disease Control and Centers for Disease Control and Elaine L. Baker,
Prevention Prevention Director, Management Analysis and Services
Office, Centers for Disease Control and
Disease, Disability, and Injury Disease, Disability, and Injury Prevention.
Prevention and Control Prevention and Control Special [FR Doc. 2015–06653 Filed 3–23–15; 8:45 am]
Emphasis Panel (SEP): Initial Review BILLING CODE 4163–18–P
Special Emphasis Panel (SEP): Initial
Review In accordance with Section 10(a)(2) of
The meeting announced below the Federal Advisory Committee Act DEPARTMENT OF HEALTH AND
concerns Cooperative Research (Pub. L. 92–463), the Centers for Disease HUMAN SERVICES
Agreements to the World Trade Center Control and Prevention (CDC)
Health Program (U01) PAR 12–126, announces a meeting for the initial National Institutes of Health
initial review. review of applications in response to
In accordance with Section 10(a)(2) of Funding Opportunity Announcements National Heart, Lung, and Blood
the Federal Advisory Committee Act (FOA) GH11–002, Conducting Public Institute; Notice of Closed Meeting
(Pub. L. 92–463), the Centers for Disease Health Research in Thailand by the
Control and Prevention (CDC) Pursuant to section 10(d) of the
Ministry of Public Health (MOPH); FOA
announces the aforementioned meeting: Federal Advisory Committee Act, as
GH12–004M, Conducting Public Health
Time and Date: amended (5 U.S.C. App.), notice is
Research in South Africa by the
hereby given of the following meeting.
8:00 a.m.–5:00 p.m., April 14, 2015 National Health Laboratory Service
(Closed) (NHLS); FOA GH12–005, Conducting The meeting will be closed to the
8:00 a.m.–12:00 p.m., April 15, 2015 Public Health Research in China; and public in accordance with the
(Closed) FOA GH14–002, Addressing Emerging provisions set forth in sections
Infectious Diseases in Bangladesh. 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Place: Atlanta Marriott Century as amended. The grant applications and
Center, 2000 Century Boulevard NE., Time and Date: 8:30 a.m.–1:00 p.m.,
EST, April 15, 2015 (Closed). the discussions could disclose
Atlanta, Georgia 30345, Telephone: confidential trade secrets or commercial
(404) 325–0000. Place: Teleconference. property such as patentable material,
Status: The meeting will be closed to Status: The meeting will be closed to and personal information concerning
the public in accordance with the public in accordance with individuals associated with the grant
provisions set forth in Section 552b(c) provisions set forth in Section 552b(c) applications, the disclosure of which
(4) and (6), Title 5 U.S.C., and the (4) and (6), Title 5 U.S.C., and the would constitute a clearly unwarranted
Determination of the Director, Determination of the Director, invasion of personal privacy.
Management Analysis and Services Management Analysis and Services
Office, CDC, pursuant to Public Law 92– Name of Committee: National Heart, Lung,
Office, CDC, pursuant to Public Law 92– and Blood Institute Special Emphasis Panel
463.
463. Pathobiology of Asthma.
Matters To Be Discussed: The meeting
will include the initial review, Matters for Discussion: The meeting Date: April 14, 2015.
discussion, and evaluation of will include the initial review, Time: 1:30 p.m. to 5:00 p.m.
discussion, and evaluation of Agenda: To review and evaluate grant
applications received in response to
applications received in response to applications.
‘‘Cooperative Research Agreements
FOA GH11–002, Conducting Public Place: National Institutes of Health, 6705
Related to the World Trade Center
Health Research in Thailand by the Rockledge Drive, Room 7180, Bethesda, MD
Health Program (U01) PAR 12–126.’’
Ministry of Public Health (MOPH); FOA 20817, (Telephone Conference Call).
Contact Person for More Information: Contact Person: Tony L Creazzo, Ph.D.,
Nina Turner, Ph.D., Scientific Review GH12–004, Conducting Public Health
Scientific Review Officer, Office of Scientific
Officer, CDC/NIOSH, 1095 Willowdale Research in South Africa by the
Review/DERA, National Heart, Lung, and
Road, Mailstop G905, Morgantown, National Health Laboratory Service
Blood Institute, 6701 Rockledge Drive, Room
West Virginia 26505, Telephone: (304) (NHLS); FOA GH12–005, Conducting
7180, Bethesda, MD 20892–7924, 301–435–
285–5975. Public Health Research in China; and 0725 creazzotl@mail.nih.gov.
The Director, Management Analysis FOA GH14–002, Addressing Emerging
(Catalogue of Federal Domestic Assistance
and Services Office, has been delegated Infectious Diseases in Bangladesh.
Program Nos. 93.233, National Center for
the authority to sign Federal Register Contact Person for More Information: Sleep Disorders Research; 93.837, Heart and
notices pertaining to announcements of Hylan Shoob, Scientific Review Officer, Vascular Diseases Research; 93.838, Lung
meetings and other committee Center for Global Health (CGH) Science Diseases Research; 93.839, Blood Diseases
management activities, for both the Office, CGH, CDC, 1600 Clifton Road and Resources Research, National Institutes
Centers for Disease Control and NE., Mailstop D–69, Atlanta, Georgia of Health, HHS)
Prevention and the Agency for Toxic 30033, Telephone: (404) 639–4796. Dated: March 18, 2015.
mstockstill on DSK4VPTVN1PROD with NOTICES

Substances and Disease Registry.
The Director, Management Analysis Michelle Trout,
Elaine L. Baker, and Services Office, has been delegated Program Analyst, Office of Federal Advisory
Director, Management Analysis and Services the authority to sign Federal Register Committee Policy.
Office, Centers for Disease Control and notices pertaining to announcements of [FR Doc. 2015–06594 Filed 3–23–15; 8:45 am]
Prevention. meetings and other committee
BILLING CODE 4140–01–P
[FR Doc. 2015–06650 Filed 3–23–15; 8:45 am] management activities, for both the
BILLING CODE 4163–18–P Centers for Disease Control and

VerDate Sep<11>2014 01:09 Mar 24, 2015 Jkt 235001 PO 00000 Frm 00063 Fmt 4703 Sfmt 9990 E:\FR\FM\24MRN1.SGM 24MRN1

Document Created: 2015-12-18 11:45:16
Document Modified: 2015-12-18 11:45:16

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		8:30 a.m.-1:00 p.m., EST, April 15, 2015 (Closed).
FR Citation		80 FR 15610

80 FR 15610 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

DEPARTMENT OF HEALTH AND HUMAN SERVICESCenters for Disease Control and Prevention

Federal Register Volume 80, Issue 56 (March 24, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention